Key result
Chemotherapy-induced pulmonary toxicity requires a high index of clinical suspicion for prompt diagnosis and early withdrawal of the offending drug.
Why the study?
What are the risks and characteristics of chemotherapy-induced pulmonary toxicity?
What are the risks and characteristics of chemotherapy-induced pulmonary toxicity?
Clinicians should maintain a high index of suspicion for chemotherapy-induced lung toxicity in cancer patients with respiratory symptoms, as early drug withdrawal is crucial.
Prompts early suspicion of pulmonary toxicity in symptomatic chemotherapy recipients; leaves open needs for prospective incidence data and risk stratification.
In Brief Chemotherapy is the cornerstone of treatment in many stages of cancer. Because there are many diagnostic options when a patient with cancer presents with nonspecific, respiratory, clinical manifestations, a multidisciplinary diagnostic approach is warranted. The top priority is to rule out life-threatening causes such as lung infection, which could be properly treated if a prompt, accurate diagnosis is given. Reaching a definitive diagnosis may require the use of one or more invasive techniques. This review highlights the risks and characteristics of chemotherapy-induced pulmonary toxicity caused by those agents that have been commonly used to treat cancer in the last decade. Clinicians should keep a high index of suspicion when a possible diagnosis of chemotherapy-induced lung toxicity is concerned, because early withdrawal of the offending drug is the most efficacious therapy. Lung side effects of chemotherapy can mimic many other lung diseases. To establish a fast, accurate diagnosis, a high degree of clinical suspicion is needed. Knowledge of this area of pulmonary medicine will help physicians increase their skills in diagnosing patients undergoing chemotherapy with concomitant respiratory difficulties.
No takes yet. Share an insight, caveat, or question.
Roig et al. (2006) conducted a review in Chemotherapy-induced pulmonary toxicity. Cytotoxic Drugs was evaluated. Chemotherapy-induced pulmonary toxicity requires a high index of clinical suspicion for prompt diagnosis and early withdrawal of the offending drug.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: